4DMedical is trading 5.35% down now at $3.54 after no specific September 16, 2026 catalyst was identified.
- Available coverage references an earlier U.S. legislative proposal and July trading-halt information, rather than a fresh announcement.
- Major U.S. indices were broadly flat in the supplied data, offering no clear broader-market explanation.
- The company had gained 8.72% on September 15.